These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1151 related articles for article (PubMed ID: 23989056)
1. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056 [TBL] [Abstract][Full Text] [Related]
2. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis. Tamura K; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Ideno N; Aso T; Miyazaki T; Ohuchida K; Takahata S; Ito T; Ushijima Y; Oda Y; Mizumoto K; Tanaka M Surgery; 2015 Feb; 157(2):277-84. PubMed ID: 25530484 [TBL] [Abstract][Full Text] [Related]
3. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108 [TBL] [Abstract][Full Text] [Related]
4. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Ohtsuka T; Kono H; Tanabe R; Nagayoshi Y; Mori Y; Sadakari Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M Am J Surg; 2012 Jul; 204(1):44-8. PubMed ID: 21996346 [TBL] [Abstract][Full Text] [Related]
5. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis. Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549 [TBL] [Abstract][Full Text] [Related]
6. Molecular Evidence for Monoclonal Skip Progression in Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas. Date K; Ohtsuka T; Fujimoto T; Tamura K; Kimura H; Matsunaga T; Mochidome N; Miyazaki T; Mori Y; Oda Y; Nakamura M; Tanaka M Ann Surg; 2017 May; 265(5):969-977. PubMed ID: 28398963 [TBL] [Abstract][Full Text] [Related]
7. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541 [TBL] [Abstract][Full Text] [Related]
8. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958 [TBL] [Abstract][Full Text] [Related]
9. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms. Gaujoux S; Parvanescu A; Cesaretti M; Silve C; Bieche I; Rebours V; Lévy P; Sauvanet A; Cros J Ann Surg Oncol; 2019 Aug; 26(8):2640-2650. PubMed ID: 31025231 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Ideno N; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Aso T; Aishima S; Miyasaka Y; Ohuchida K; Ueda J; Takahata S; Oda Y; Mizumoto K; Tanaka M Pancreas; 2015 Mar; 44(2):311-20. PubMed ID: 25479586 [TBL] [Abstract][Full Text] [Related]
11. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas. Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H Surgery; 2016 Aug; 160(2):306-17. PubMed ID: 27236360 [TBL] [Abstract][Full Text] [Related]
12. GNAS and KRAS mutational analyses of intraductal papillary neoplasms of the pancreas and bile duct developing in the same individual: A case report. Date K; Ohtsuka T; Fujimoto T; Gotoh Y; Nakashima Y; Kimura H; Matsunaga T; Mori Y; Mochidome N; Miyazaki T; Oda Y; Tanaka M; Nakamura M Pancreatology; 2015; 15(6):713-6. PubMed ID: 26506885 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Matthaei H; Norris AL; Tsiatis AC; Olino K; Hong SM; dal Molin M; Goggins MG; Canto M; Horton KM; Jackson KD; Capelli P; Zamboni G; Bortesi L; Furukawa T; Egawa S; Ishida M; Ottomo S; Unno M; Motoi F; Wolfgang CL; Edil BH; Cameron JL; Eshleman JR; Schulick RD; Maitra A; Hruban RH Ann Surg; 2012 Feb; 255(2):326-33. PubMed ID: 22167000 [TBL] [Abstract][Full Text] [Related]
14. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant. Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889 [TBL] [Abstract][Full Text] [Related]
15. Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm. Miyasaka Y; Ohtsuka T; Tamura K; Mori Y; Shindo K; Yamada D; Takahata S; Ishigami K; Ito T; Tokunaga S; Oda Y; Mizumoto K; Nakamura M; Tanaka M Ann Surg; 2016 Jun; 263(6):1180-7. PubMed ID: 26334637 [TBL] [Abstract][Full Text] [Related]
16. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521 [TBL] [Abstract][Full Text] [Related]
17. Patterns of Recurrence After Resection of IPMN: Who, When, and How? Marchegiani G; Mino-Kenudson M; Ferrone CR; Morales-Oyarvide V; Warshaw AL; Lillemoe KD; Castillo CF Ann Surg; 2015 Dec; 262(6):1108-14. PubMed ID: 25793719 [TBL] [Abstract][Full Text] [Related]
18. Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Pea A; Yu J; Rezaee N; Luchini C; He J; Dal Molin M; Griffin JF; Fedor H; Fesharakizadeh S; Salvia R; Weiss MJ; Bassi C; Cameron JL; Zheng L; Scarpa A; Hruban RH; Lennon AM; Goggins M; Wolfgang CL; Wood LD Ann Surg; 2017 Jul; 266(1):133-141. PubMed ID: 27433916 [TBL] [Abstract][Full Text] [Related]
19. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas. Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244 [TBL] [Abstract][Full Text] [Related]
20. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms. Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]